We showed that UDCA is able to suppress the hypoxic HCC cell–induced tube formation and decrease HIF-1α and VEGF levels, indicating it may be an effective anti-angiogenesis agent in the hypoxic condition. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.